The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis

Poly(ADP-ribose) polymerase (PARP) is involved in the pathogenesis of cell dysfunction, inflammation and organ failure during septic shock. The goal of the current study was to investigate the efficacy and safety of the clinically approved PARP inhibitor olaparib in experimental models of oxidative...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmacol Res
Hlavní autoři: Ahmad, Akbar, Vieira, Juliana de Camargo, de Mello, Aline Haas, de Lima, Thais Martins, Ariga, Suely Kubo, Barbeiro, Denise Frediani, Barbeiro, Hermes Vieira, Szczesny, Bartosz, Törö, Gábor, Druzhyna, Nadiya, Randi, Elisa B., Marcatti, Michela, Toliver-Kinsky, Tracy, Kiss, András, Liaudet, Lucas, Salomao, Reinaldo, Soriano, Francisco Garcia, Szabo, Csaba
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6662650/
https://ncbi.nlm.nih.gov/pubmed/31071432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2019.104263
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky